E
MindBio Therapeutics Corp. MBIO
CNSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -4.71% -57.70% -94.82% 0.29% 68.27%
Depreciation & Amortization 83.49% -- -21.41% 63.58% 98.11%
Other Operating Expenses -- -44.20% -- -- --
Total Operating Expenses 20.07% -53.43% -97.89% 6.88% 75.71%
Operating Income -910.84% 53.43% 75.02% 178.00% 126.02%
Income Before Tax -857.85% 75.41% 92.33% 124.57% 89.43%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -857.85% 75.41% 92.33% 124.57% 89.43%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -300.00% -- -- --
Net Income -847.13% 75.04% 92.33% 124.57% 89.43%
EBIT -910.84% 53.43% 75.02% 178.00% 126.02%
EBITDA -319.75% -- -- 206.31% 200.42%
EPS Basic -500.00% 81.82% 80.00% 105.71% 96.84%
Normalized Basic EPS -450.00% 85.71% 77.78% 104.55% 96.67%
EPS Diluted -500.00% 81.82% 80.00% 105.71% 96.84%
Normalized Diluted EPS -450.00% 85.71% 77.78% 104.55% 96.67%
Average Basic Shares Outstanding 34.90% 21.66% -61.06% 347.92% 287.22%
Average Diluted Shares Outstanding 34.90% 21.66% -61.06% 347.92% 287.22%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings